New Rochelle, NY, August 13, 2014—About 1 in 5 Medicare patients is discharged from hospice care alive, whether due to patients' informed choice, a change in their condition, or inappropriate actions by the hospice to save on hospitalization costs related to terminal illness. How live discharge rates differ between hospice programs and geographic regions, and when those rates should raise red flags are among the issues explored in the article "A National Study of Live Discharges from Hospice" , published in Journal of Palliative Medicine, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers/. The article is available free on the Journal of Palliative Medicine website until September 13, 2014.
Joan M. Teno, MD, Pedro Gozalo, PhD, and Vincent Mor, PhD, Brown University School of Public Health (Providence, RI), and Michael Plotzke, PhD, Abt Associates (Cambridge, MA), examined all of the Medicare hospice discharges in the U.S. between January 1 to December 31, 2010. For the patients discharged alive, they gathered data on survival for up to 6 months, subsequent hospitalizations, and Medicare payments during the 30 days after live hospice discharge. The authors provide details on the substantial variation they found in the rates of live discharges across states and between individual hospices, in particular comparing not-for-profit to for-profit hospice programs and more mature programs versus those that had been in operation for 5 years or less.
"The phenomenon of hospice patients 'graduating' because they get better with hospice care is well known. But, all patients discharged days to weeks before death is very strange," says Charles F. von Gunten, MD, PhD, Editor-in-Chief of Journal of Palliative Medicine and Vice President, Medical Affairs, Hospice and Palliative Medicine for OhioHealth (Columbus, OH).
Journal of Palliative Medicine is the official journal of the Center to Advance Palliative Care (CAPC) and an official journal of the Hospice and Palliative Nurses Association.
About the Journal
Journal of Palliative Medicine, published monthly in print and online, is an interdisciplinary journal that reports on the clinical, educational, legal, and ethical aspects of care for seriously ill and dying patients. The Journal includes coverage of the latest developments in drug and non-drug treatments for patients with life-threatening diseases including cancer, AIDS, cardiac disease; pulmonary, neurological, and respiratory conditions; and other diseases. The journal reports on the development of palliative care programs around the United States and the world, and on innovations in palliative care education. Tables of content and a sample issue may be viewed on the Journal of Palliative Medicine website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in promising areas of science and biomedical research, including Population Health Management, AIDS Patient Care and STDs, and Briefings in Palliative, Hospice, and Pain Medicine & Management, a weekly e-News Alert. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, newsmagazines, and books is available on the Mary Ann Liebert, Inc., publishers website website.
Mary Ann Liebert, Inc.
140 Huguenot Street
New Rochelle, NY 10801-5215
Phone (914) 740-2100
Fax (914) 740-2101
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.